Platnu

Description

Platnu is an Ayurvedic-labelled soft gelatin capsule formulation containing Tinospora cordifolia extract 150 mg, Carica papaya extract 1100 mg, goat milk powder 100 mg, and Vitamin E 10 mg, according to the supplied composition.

The formulation combines plant-derived ingredients with goat milk powder and Vitamin E. Tinospora cordifolia and Carica papaya have a history of use in traditional health practices. However, the safety and effectiveness of this specific combination for treating dengue have not been established by the ingredient list alone.

Important: Platnu should not be promoted as a proven dengue treatment or as a replacement for medical evaluation, monitoring, or supportive care.

Therapeutic Segment

Primary Segment: Ayurvedic and Herbal Formulations
Related Segment: General Wellness

Although the supplied business category is Anti-Dengue, that classification should be used cautiously. There is insufficient reliable clinical evidence to establish that this specific formulation treats dengue or prevents its complications. A safer website classification is Ayurvedic Herbal Formulations unless an authorised indication explicitly supports another claim.

Uses of Platnu

Platnu is an Ayurvedic-labelled formulation containing botanical extracts and nutritional ingredients. Its intended use should follow the approved product label and applicable regulatory authorisation.

The ingredients have been used in traditional or nutritional contexts, but the supplied composition alone does not establish that Platnu:

• Treats dengue fever.
• Increases platelet counts in dengue patients.
• Prevents dengue-related bleeding or other complications.
• Shortens recovery time from dengue.
• Prevents dengue infection.

Anyone with suspected dengue should seek medical assessment and follow professional advice regarding monitoring, hydration, and warning signs.

Key Product Features

• Botanical ingredients: Contains Tinospora cordifolia and Carica papaya extracts.
• Additional ingredients: Includes goat milk powder and Vitamin E.
• Soft gelatin dosage form: Supplied as soft gelatin capsules, according to the provided product details.
• Ayurvedic-labelled product: The final product classification and permissible claims should match its regulatory approval and approved labelling.

These features describe the composition and presentation, not proof of clinical effectiveness for dengue.

Ingredient Overview

Tinospora cordifolia Extract – 150 mg: Also known as guduchi or giloy, this plant has a history of use in traditional medicine. However, reports of liver injury associated with Tinospora products mean that safety cannot be assumed simply because an ingredient is traditionally used.

Carica papaya Extract – 1100 mg: Papaya-derived preparations have been investigated for several health applications, including their possible effects on platelet counts in dengue. The evidence remains insufficient to establish that this specific extract and combination safely or reliably treat dengue. Extract type, plant part, standardisation, and clinical evidence matter.

Goat Milk Powder – 100 mg: Provides a milk-derived ingredient. It is not established as a dengue treatment. Patients with milk allergy should check the product’s complete ingredient and allergen information before use.

Vitamin E – 10 mg: Vitamin E is a fat-soluble vitamin that contributes to normal physiological functions. Its presence does not establish a therapeutic effect against dengue.

Possible Side Effects and Safety Considerations

The safety profile of the complete Platnu formulation cannot be determined from the supplied ingredient list alone. Potential concerns include:

• Liver injury: Tinospora cordifolia products have been associated with liver injury in published reports.
• Allergic reactions: Goat milk powder may be unsuitable for people with milk allergy.
• Product variability: The safety of botanical extracts can depend on plant part, extraction method, standardisation, quality, and contamination controls.
• Interactions: Herbal ingredients may interact with medicines or be unsuitable for people with certain health conditions.

Stop using the product and seek medical advice if symptoms suggest an adverse reaction. Yellowing of the eyes or skin, dark urine, severe abdominal pain, or persistent vomiting requires prompt medical assessment.

Important Safety Information for Suspected Dengue

• Platnu must not replace medical care for suspected or confirmed dengue.
• There is no established evidence that this specific formulation prevents dengue complications or reliably increases platelet counts.
• Seek urgent medical care for severe abdominal pain, persistent vomiting, bleeding, unusual drowsiness or restlessness, difficulty breathing, or signs of dehydration.
• Avoid aspirin and non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, unless a treating clinician specifically advises otherwise, because they may increase bleeding risk in dengue.
• A healthcare professional should guide fluid intake, monitoring, and other treatment decisions.
• People with liver disease, those taking other medicines, pregnant or breastfeeding individuals, and children should obtain professional advice before using this formulation.

Dosage and Administration

Use Platnu only according to its approved label and advice from a qualified healthcare professional. The appropriate dose and duration cannot be determined from the supplied composition and pack size alone.

Do not self-medicate for suspected dengue or delay a medical assessment while taking an herbal product. Confirm the approved dosage, age restrictions, contraindications, and directions before publishing consumer-facing instructions.

Storage Instructions

Store Platnu according to the instructions on its approved packaging. Keep the soft gelatin capsules in their original packaging, away from excessive heat, moisture, and direct sunlight. Keep the product out of children’s reach and do not use it after the expiry date.